Developmental Research Program

$89,620P50FY2010CANIH

University Of Tx Md Anderson Can Ctr, Houston TX

Investigators

Linked publications & trials

Paper 39605508 Paper 38922360 Paper 38364811 Paper 38279277 Paper 37864337 Paper 37380216 Paper 37154098 Paper 37038957 Paper 36835335 Paper 36469840 Paper 36401704 Paper 35992327 Paper 35954359 Paper 35953818 Paper 35545008 Paper 35483739 Paper 35115431 Paper 35081345 Paper 35022962 Paper 34731628 Paper 34648891 Paper 34583979 Paper 34518313 Paper 34417750 Paper 34391578 Paper 34348992 Paper 34321288 Paper 34267857 Paper 34222745 Paper 34065218 Paper 33958211 Paper 33821990 Paper 33793044 Paper 33609609 Paper 33589518 Paper 33567287 Paper 33563487 Paper 33551196 Paper 33438761 Paper 33367660 Paper 33246098 Paper 33157050 Paper 33149280 Paper 33016929 Paper 32852746 Paper 32835719 Paper 32805208 Paper 32747824 Paper 32737156 Paper 32702466 Paper 32499298 Paper 32294438 Paper 32265228 Paper 32223560 Paper 32151751 Paper 32109374 Paper 32037398 Paper 31984309 Paper 31980487 Paper 31911539 Paper 31855955 Paper 31847695 Paper 31843871 Paper 31799396 Paper 31794514 Paper 31741544 Paper 31730714 Paper 31714586 Paper 31645905 Paper 31628143 Paper 31623857 Paper 31560538 Paper 31512530 Paper 31412816 Paper 31289363 Paper 31273750 Paper 31258039 Paper 31225906 Paper 31221496 Paper 31128110 Paper 31126961 Paper 31109659 Paper 31106233 Paper 31068700 Paper 30984972 Paper 30956779 Paper 30913308 Paper 30861414 Paper 30773264 Paper 30442683 Paper 30420565 Paper 30419609 Paper 30414738 Paper 30356138 Paper 30315273 Paper 30300578 Paper 30291344 Paper 30266942 Paper 30213435 Paper 30181330

Abstract

PROJECT SUMMARY (See instructions): The overall goal of the University of Texas M. D. Anderson Gancer Center Gynecologic SPORE for Uterine Cancers is to provide initial funding to support innovative translational studies and exploratory research in the area of gynecologic oncology and uterine cancer research. The support of translational research projects that can generate clinically testable hypotheses aimed at reducing the incidence and mortality of uterine cancers or leading to improved therapeutic outcomes or quality of life for uterine cancer patients will be emphasized. Pre-proposals in the form of project abstracts (1/2 -1 page) will be solicited by the Program and applicants of responsive abstracts invited to submit full Pilot Project proposals to the program. Proposals will follow an abbreviated ROI research grant format and be up to 5 pages in length. The Developmental Research Program Directors, in conjunction with the Executive Committee of the SPORE, will help investigators submitting proposals formulate relevant translational research aims and plans, as many investigators may not have previous expertise in this area. This process will therefore be a major educational activity that is anticipated to further stimulate translational research in gynecologic oncology and encourage the participation of both basic researchers and clinicians in translational research. Opportunities for competing renewals will be extended to all awardees. The proposals will be reviewed by members of the SPORE Executive Committee. Internal Advisory Committee, and External Advisory Committee. With the input from the Internal and External Advisory Committees, the SPORE Executive Committee will make the final selection of Pilot Projects for funding. Projects will be funded for 1 year with the possibility of renewal for an additional year. It is anticipated that the program will fund 2 Pilot Projects each year. All projects will be reviewed at the end of their first year with written progress reports and oral presentations at one of the SPORE meetings or retreats. Projects receiving an additional year of support will submit a final progress report at the end of their second year. Examples of Pilot Project abstracts are presented to illustrate the type of multidisciplinary translational research proposals that are anticipated to be received by the program.

View original record on NIH RePORTER →